South San Francisco, CA · Founded 2022 · Privately Held (backing)
Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.
Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025
No prints on record
No secondary trades in Shenandoah Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Shenandoah Therapeutics stock.
